Peptides in fitness: what you need to know before you inject anything

Peptides are emerging as a hot topic in fitness. They are marketed as the next big thing in fat loss, muscle recovery and ‘anti-aging’, often promising faster results with less effort.

But here’s the uncomfortable truth: Many injectable peptide products promoted in the fitness world are not approved by the U.S. Food and Drug Administration (FDA), are not supported by strong scientific evidence, and in some cases may pose serious health risks.

What is a Peptide?

A peptide is a short chain of amino acids, the building blocks of proteins. Your body naturally produces thousands of peptides, including hormones such as insulin and glucagon-like peptide-1 (GLP-1). Some peptides act like hormones, sending signals that control hunger, growth, sleep or other functions.

Because peptides can affect physiological systems, some have been developed for use as medicine. This is where confusion often arises.

Certain peptide-based medications, such as GLP-1 receptor agonists, are prescribed by physicians and are FDA-approved medications, backed by large clinical trials and extensive safety monitoring. Others sold online or through certain “wellness clinics” are not FDA approved, may be marketed as “research chemicals” and often carry labels stating they are not intended for human use. That distinction is crucial.

Peptide-based medications that Are FDA approved

Two well-known examples of peptide-based medications are semaglutide (Wegovy) and tirzepatide (Zepbound), which are approved for chronic weight management in specific patient populations.

Large randomized controlled trials published in the New England Journal of Medicine showed impressive results:

• In the STEP-1 trialpeople taking semaglutide lost about On average 15% of their body weight is left 68 weeks.
• In the SURMOUNT-1 trialTirzepatide also led to significant weight loss compared to placebowith highher doses approach 20% average weight reducation.

These drugs have undergone years of research, dose studies, and regulatory review, and their safety continues to be monitored after approval.

Importantly, however, these results do not generalize to other peptides that have not undergone similar testing.

Peptides are being pushed by fitness influencers

In fitness circles you may hear about BPC-157 and TB-500, often promoted for muscle recovery, injury healing or tissue regeneration. BPC-157 is part of a popular trend called the ‘Wolverine stack’, which refers to fictional fast-healing abilities.

The scientific reality is much more limited:

• These compounds are not approved by the FDA for medical use.
• There is little to no high-quality clinical research in humans demonstrating effectiveness for musculoskeletal healing or performance enhancement in healthy individuals.
• Much of the positive data comes from animal or laboratory studies, which are useful for generating hypotheses but cannot demonstrate efficacy or safety in humans.
• Many therapies that appear promising in preclinical research ultimately fail when tested in humans.
• There is currently insufficient evidence to conclude that these substances improve recovery from injury in humans.

Safety issues

Another major issue is product quality and regulations. Products sold as investigational peptides are generally not subject to FDA oversight of manufacturing. As a result:

• The dose stated on the label may be inaccurate.
• The product may contain contaminants or impurities.
• Sterility cannot be guaranteed.
• The vial may not contain the advertised substance at all.

Aside from a lack of supervision, there are risks associated with self-injection, such as: iinfection, tissue damage and dosing errorsare also concerns.

Concerns about quality should not be dismissed. Investigations into peptides sold online have revealed counterfeit or substandard products, including those marketed as semaglutide that contain various active ingredients. The FDA has also issued warnings about dosing errors and adverse events associated with improperly prepared or compounded GLP-1 medications.

If quality problems can occur with high-demand prescription drugs, the risk may be even greater with unregulated investigational peptides.

The long-term unknowns

One of the biggest warning signs is what we simply don’t know. For many of these compounds, there are no long-term human safety studies evaluating:

• Cardiovascular risk
• Risk of cancer
• Immune effects
• Endocrine disruption
• Fertility outcomes
• Long-term metabolic consequences

Using substances without this information essentially means that people are participating in uncontrolled personal experiments – without appropriate monitoring, safety oversight or systematic data collection.

What happens when you stop?

Even with FDA-approved medications like semaglutide And tirzepatidethis is evident from research a lot of people gain weight again after stopping treatment. This is important indicates that tthese medications not permanently ‘repair’ metabolism. When the outcomes change after stopping well-studied medications, the effects of unapproved peptides – both benefits and riskss – are even more unpredictable.

Why this matters

Social media influencers often show dramatic transformations and claims That are peptides A “Biohacking” attempt or “Noptimization at ext level.” But wchicken the goal is Hecontralto, performance or improving body compositionthe strongest scientific support stsick indicates sustainable behaviorS-like the one outlined in the ACE 7 Core drivers of healthy Alive^T.M.

Are also important to notewhy people consider these options. Interest in experimental therapies often arises out of frustration, not vanity. cchronic pain, slow recovery, persistent fatigue or unresolved health issues approxn to encourage people to look for solutions outside the traditional concern.

These challenges are real – and they deserve thoughtful medical evaluation, not shortcuts of uncertain risk and value.

Sometimes progress comes from:

• A different rehabilitation approach
• A consultation with a specialist
• A more extensive medical evaluation
• Addressing sleep, nutrition, stress or training load and volume

Sports and health professionals can best support clients by helping them pursue safe, evidence-based and sustainable strategies, rather than pursuing unproven interventions.

The bottom line

If a substance is not FDA-approved, not supported by strong human clinical studies, sold online as “research use only,” and injected without medical supervision, the risks are real and the benefits uncertain.

It is not without reason that science is moving forward cautiously. First and foremost, to protect people. Certain aspects of the fitness and wellness industry are changing rapidly as novelty and hype attract attention and sales. Before you inject anything, ask:

• Has this been tested in large human studies?
• Is it FDA approved for this use?
• Are the long-term risks understood?
• Am I influenced more by marketing than by data?

If the currently unapproved peptides are ultimately shown to be safe and effective through rigorous research, their use may become appropriate. But until then, skepticism about gray market peptides is not negative. Instead, it is a responsible health and exercise professional who follows the evidence.

References

Aronne, LJ et al. (2024). Continued treatment with tirzepatide for maintenance of weight reduction in obese adults: the SURMOUNT-4 randomized clinical trial. Journal of the American Medical Association331, 1, 38–48.

Jastreboff, AM et al. (2022). Tirzepatide once a week for the treatment of obesity. New England Journal of Medicine387, 3, 205–216.

Rubino, D. et al. (2021). Effect of continued weekly subcutaneous semaglutide versus placebo on weight loss maintenance in overweight or obese adults: the STEP 4 randomized clinical trial. Journal of the American Medical Association325, 14, 1414–1425.

Wilding, JPH et al. (2021). Semaglutide once weekly in overweight or obese adults. New England Journal of Medicine384, 11, 989–1002.